Eva M M Strijbis (Eva M Strijbis, Eva Mm Strijbis, Emm Strijbis, Eva Strijbis, Eva E M Strijbis, E M M Strijbis)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 44

Top Topics

Disease Activity

Multiple Sclerosis

Top Venues

Multiple sclerosis (Houndmills, Basingstoke, England)

Journal of neurology

Journal of neurology, neurosurgery, and psychiatry

This page only lists publications with an associated author ORCID identifier.

Publications

Daan J de Jong, Eva M M Strijbis, Joep Killestein
Information from ecological momentary assessments lead to over-medicalization: Commentary. Multiple sclerosis (Houndmills, Basingstoke, England) (2024)
Samantha Noteboom, Moritz Seiler, Claudia Chien, Roshan Prakash Rane, Frederik Barkhof, Eva M M Strijbis, Friedemann Paul, Menno Michiel Schoonheim, Kerstin Ritter
Evaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis. Journal of neurology 271 (8) (2024)
Alyssa A Toorop, Samantha Noteboom, Martijn D Steenwijk, Job W Gravendeel, Bas Jasperse, Frederik Barkhof, Eva M M Strijbis, Theo Rispens, Menno Michiel Schoonheim, Zoé Léonie Elise van Kempen, Joep Killestein
Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (2) (2024)
Samantha Noteboom, Moritz Seiler, Claudia Chien, Roshan Prakash Rane, Frederik Barkhof, Eva M M Strijbis, Friedemann Paul, Menno Michiel Schoonheim, Kerstin Ritter
Evaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis. Journal of neurology (2024)
Samantha Noteboom, Moritz Seiler, Claudia Chien, Roshan Prakash Rane, Frederik Barkhof, Eva M M Strijbis, Friedemann Paul, Menno Michiel Schoonheim, Kerstin Ritter
Evaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis. Journal of neurology 271 (8) (2024)
Alyssa A Toorop, Samantha Noteboom, Martijn D Steenwijk, Job W Gravendeel, Bas Jasperse, Frederik Barkhof, Eva M M Strijbis, Theo Rispens, Menno Michiel Schoonheim, Zoé Léonie Elise van Kempen, Joep Killestein
Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (2024)
Samantha Noteboom, Moritz Seiler, Claudia Chien, Roshan Prakash Rane, Frederik Barkhof, Eva M M Strijbis, Friedemann Paul, Menno Michiel Schoonheim, Kerstin Ritter
Evaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis. Journal of neurology 271 (8) (2024)
Tom A Fuchs, Menno Michiel Schoonheim, Robert Zivadinov, Michael G Dwyer, Elisa Colato, Zachary L Weinstock, Bianca Weinstock-Guttman, Eva M M Strijbis, Ralph H B Benedict
Cognitive progression independent of relapse in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (2024)
Cynthia M C Lemmens, Suzan van Amerongen, Eva M M Strijbis, Joep Killestein
Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy in Patients With Multiple Sclerosis. Neurology 102 (6) (2024)
Alyssa A Toorop, Samantha Noteboom, Martijn D Steenwijk, Job W Gravendeel, Bas Jasperse, Frederik Barkhof, Eva M M Strijbis, Theo Rispens, Menno Michiel Schoonheim, Zoé Léonie Elise van Kempen, Joep Killestein
Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (2) (2024)
Daan J de Jong, Eva M M Strijbis, Joep Killestein
Information from ecological momentary assessments lead to over-medicalization: Commentary. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (8) (2024)
Cynthia M C Lemmens, Suzan van Amerongen, Eva M M Strijbis, Joep Killestein
Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy in Patients With Multiple Sclerosis. Neurology 102 (6) (2024)
Floor C Loonstra, Daniel Álvarez Sirvent, Niccoló Tesi, Henne Holstege, Eva M M Strijbis, Alex N Salazar, Marc Hulsman, Sven J Van der Lee, Bernard M J Uitdehaag
Association of Polygenic Risk Score With Lifetime Risk of Developing Multiple Sclerosis in a Population-Based Birth-Year Cohort. Neurology 103 (7) (2024)
Cynthia M C Lemmens, Suzan van Amerongen, Eva M M Strijbis, Joep Killestein
Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy in Patients With Multiple Sclerosis. Neurology 102 (6) (2024)
Daan J de Jong, Eva M M Strijbis, Joep Killestein
Information from ecological momentary assessments lead to over-medicalization: Commentary. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (8) (2024)
Cynthia M C Lemmens, Suzan van Amerongen, Eva M M Strijbis, Joep Killestein
Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy in Patients With Multiple Sclerosis. Neurology 102 (6) (2024)
Cynthia M C Lemmens, Suzan van Amerongen, Eva M M Strijbis, Joep Killestein
Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy in Patients With Multiple Sclerosis. Neurology 102 (6) (2024)
Marcus Werner Koch, Carlos Camara-Lemarroy, Eva M M Strijbis, Jop Mostert, Victoria M Leavitt, Pavle Repovic, James D Bowen, Jacynthe Comtois, Bernard Uitdehaag, Gary R Cutter
Selecting informative patients for phase 2 progressive trials in MS: Design considerations for phase 2 clinical trials in progressive MS. Multiple sclerosis (Houndmills, Basingstoke, England) (2024)
Samantha Noteboom, Moritz Seiler, Claudia Chien, Roshan Prakash Rane, Frederik Barkhof, Eva M M Strijbis, Friedemann Paul, Menno Michiel Schoonheim, Kerstin Ritter
Evaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis. Journal of neurology 271 (8) (2024)
Daan J de Jong, Eva M M Strijbis, Joep Killestein
Information from ecological momentary assessments lead to over-medicalization: Commentary. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (8) (2024)
Cynthia M C Lemmens, Suzan van Amerongen, Eva M M Strijbis, Joep Killestein
Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy in Patients With Multiple Sclerosis. Neurology 102 (6) (2024)
Alyssa A Toorop, Samantha Noteboom, Martijn D Steenwijk, Job W Gravendeel, Bas Jasperse, Frederik Barkhof, Eva M M Strijbis, Theo Rispens, Menno Michiel Schoonheim, Zoé Léonie Elise van Kempen, Joep Killestein
Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (2) (2024)
Pam C G Molenaar, Samantha Noteboom, David R van Nederpelt, Eva A Krijnen, Julia R Jelgerhuis, Ka Hoo Lam, Gerrieke B Druijff-van de Woestijne, Kim A Meijer, Pim van Oirschot, Brigit A de Jong, Iman Brouwer, Bas Jasperse, Vincent De Groot, Bernard M J Uitdehaag, Menno Michiel Schoonheim, Eva M M Strijbis, Joep Killestein
Digital outcome measures are associated with brain atrophy in patients with multiple sclerosis. Journal of neurology (2024)
Eva M M Strijbis, Eline Me Coerver, Jop Mostert, Zoé Léonie Elise van Kempen, Joep Killestein, Jacynthe Comtois, Pavle Repovic, James D Bowen, Gary Cutter, Marcus Werner Koch
Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry (2023)
Sezgi Kaçar, Danko Coric, Giovanni Ometto, Giovanni Montesano, Alastair K Denniston, Pearse A Keane, Bernard M J Uitdehaag, David P Crabb, Menno M Schoonheim, Axel Petzold, Eva M M Strijbis
Exploring Vitreous Haze as a Potential Biomarker for Accelerated Glymphatic Outflow and Neurodegeneration in Multiple Sclerosis: A Cross-Sectional Study. Brain sciences 14 (1) (2023)
Sezgi Kaçar, Danko Coric, Giovanni Ometto, Giovanni Montesano, Alastair K Denniston, Pearse A Keane, Bernard M J Uitdehaag, David P Crabb, Menno M Schoonheim, Axel Petzold, Eva M M Strijbis
Exploring Vitreous Haze as a Potential Biomarker for Accelerated Glymphatic Outflow and Neurodegeneration in Multiple Sclerosis: A Cross-Sectional Study. Brain sciences 14 (1) (2023)
Sezgi Kaçar, Danko Coric, Giovanni Ometto, Giovanni Montesano, Alastair K Denniston, Pearse A Keane, Bernard M J Uitdehaag, David P Crabb, Menno M Schoonheim, Axel Petzold, Eva M M Strijbis
Exploring Vitreous Haze as a Potential Biomarker for Accelerated Glymphatic Outflow and Neurodegeneration in Multiple Sclerosis: A Cross-Sectional Study. Brain sciences 14 (1) (2023)
Alyssa A Toorop, Zoé Léonie Elise van Kempen, Maurice Steenhuis, Jessica Nielsen, L G F Sinnige, Gert van Dijk, Christiaan M Roosendaal, Edo P J Arnoldus, Elske Hoitsma, Birgit I Lissenberg-Witte, Brigit A de Jong, Bob W van Oosten, Eva M M Strijbis, Bernard M J Uitdehaag, Theo Rispens, Joep Killestein, null null
Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry (2023)
Raffaele Palladino, Eva M M Strijbis
How Far Are We in Translating the Multiple Sclerosis Prodromes in Clinical Practice? Neurology (2023)
Alyssa A Toorop, Laura Hogenboom, Karien Bloem, Merve Kocyigit, Nadine W M Commandeur, Anne Wijnants, Birgit I Lissenberg-Witte, Eva M M Strijbis, Bernard M J Uitdehaag, Theo Rispens, Joep Killestein, Zoé Léonie Elise van Kempen
Ocrelizumab concentration and antidrug antibodies are associated with B-cell count in multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry (2023)
Eline Me Coerver, S Janssens, A Ahmed, M H J Wessels, Z L E Van Kempen, M M S Jasperse, F Barkhof, Marcus Werner Koch, J Mostert, B M J Uitdehaag, Joep Killestein, Eva M M Strijbis
The association between age and inflammatory disease activity on MRI in relapse-onset multiple sclerosis during long-term follow-up. European journal of neurology (2023)
Eloy Martinez-Heras, Elisabeth Solana, Francesc Vivó, Elisabet Lopez-Soley, Alberto Calvi, Salut Alba-Arbalat, Menno Michiel Schoonheim, Eva M M Strijbis, Hugo Vrenken, Frederik Barkhof, Maria Assunta Rocca, Massimo Filippi, Elisabetta Pagani, Sergiu Groppa, Vinzenz Fleischer, Robert A Dineen, Barbara Bellenberg, Carsten Lukas, Deborah Pareto, Àlex Rovira, Jaume Sastre-Garriga, Collorone Sara, Ferran Prados, Ahmed Toosy, Olga Ciccarelli, Albert Saiz, Yolanda Blanco, Sara Llufriu
Diffusion-based structural connectivity patterns of multiple sclerosis phenotypes. Journal of neurology, neurosurgery, and psychiatry (2023)
Marcus Werner Koch, Pavle Repovic, Jop Mostert, James D Bowen, Jacynthe Comtois, Eva M M Strijbis, Bernard Uitdehaag, Gary Cutter
Threshold definitions for significant change on the timed 25-foot walk and 9-hole peg test in primary progressive multiple sclerosis. European journal of neurology (2023)
Mark Hj Wessels, Zoë Y G J van Lierop, Samantha Noteboom, Eva M M Strijbis, Johannes A Heijst, Zoé Léonie Elise van Kempen, Bastiaan Moraal, Frederik Barkhof, Bernard Mj Uitdehaag, Menno Michiel Schoonheim, Joep Killestein, Charlotte E Teunissen
Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Shira Simon, Ilse M Nauta, Arjan Hillebrand, Menno Michiel Schoonheim, Bernard Mj Uitdehaag, Maureen van Dam, Hanneke Euphemia Hulst, Martin Klein, Cornelis J Stam, Brigit A de Jong, Eva M M Strijbis
Neurophysiological MEG markers of cognitive impairment and performance validity in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Marcus Werner Koch, Ester Moral, Luis Brieva, Jop Mostert, Eva M M Strijbis, Jacynthe Comtois, Pavle Repovic, James D Bowen, Jerry S Wolinsky, Fred D Lublin, Gary R Cutter
Relapse recovery in relapsing-remitting multiple sclerosis: An analysis of the CombiRx dataset. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Alyssa A Toorop, Zoë Ygj van Lierop, Liza My Gelissen, Elske Hoitsma, Esther Mpe Zeinstra, Luuk C van Rooij, Caspar Ep van Munster, Anke Vennegoor, Jop P Mostert, Beatrijs Ha Wokke, Nynke F Kalkers, Erwin Lj Hoogervorst, Jeroen Jj van Eijk, Christiaan M Roosendaal, Jolijn J Kragt, Marijke Eurelings, Jessie van Genugten, Jessica Nielsen, Lgf Sinnige, Mark E Kloosterziel, Edo Pj Arnoldus, Gert W van Dijk, Willem H Bouvy, Mark Hj Wessels, Lynn Boonkamp, Eva M M Strijbis, Bob W van Oosten, Brigit A De Jong, Birgit I Lissenberg-Witte, Frederik Barkhof, Bastiaan Moraal, Charlotte E Teunissen, Theo Rispens, Bernard Mj Uitdehaag, Joep Killestein, Zoé Léonie Elise van Kempen
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS). Journal of neurology, neurosurgery, and psychiatry (2023)
Zoé Léonie Elise van Kempen, Koos Pj van Dam, Jim B D Keijser, Eileen W Stalman, Laura Yl Kummer, Eva M M Strijbis, Maurice Steenhuis, Anja Ten Brinke, S Marieke van Ham, Taco Kuijpers, Theo Rispens, Filip Eftimov, Luuk Wieske, Joep Killestein
Longitudinal increase of humoral responses after four SARS-CoV-2 vaccinations and infection in MS patients on fingolimod. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Eva M M Strijbis, M W Koch, B A de Jong
Quality of life should be the primary outcome for disease modifying therapy trials in MS-No. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Ka Hoo Lam, Ioan Gabriel Bucur, Pim van Oirschot, Frank de Graaf, Eva M M Strijbis, Bernard Uitdehaag, Tom Heskes, Joep Killestein, Vincent de Groot
Personalized monitoring of ambulatory function with a smartphone 2-minute walk test in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Julia Horjus, Tineke van Mourik-Banda, Marco A P Heerings, Marina Hakobjan, Ward De Witte, Dorothea J Heersema, Anne J Jansen, Eva M M Strijbis, Brigit A de Jong, Astrid E J Slettenaar, Esther M P E Zeinstra, Erwin L J Hoogervorst, Barbara Franke, Wiebe Kruijer, Peter Joseph Jongen, Leo J Visser, Geert Poelmans
Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis. International journal of molecular sciences 23 (19) (2022)
Samira Ghorbani, Emily Jelinek, Rajiv Jain, Benjamin Buehner, Cenxiao Li, Brian Mark Lozinski, Susobhan Sarkar, Deepak K Kaushik, Yifei Dong, Thomas N Wight, Soheila-Karimi Abdolrezaee, Geert J Schenk, Eva M M Strijbis, Jeroen Geurts, Ping Zhang, Chang-Chun Ling, Voon Wee Yong
Versican promotes T helper 17 cytotoxic inflammation and impedes oligodendrocyte precursor cell remyelination. Nature communications 13 (1) (2022)
Alyssa A Toorop, Zoë Y G J van Lierop, Eva M M Strijbis, Charlotte E Teunissen, Axel Petzold, Mike P Wattjes, Frederik Barkhof, Brigit A de Jong, Zoé Léonie Elise van Kempen, Joep Killestein
Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab. Neurology(R) neuroimmunology & neuroinflammation 8 (1) (2020)
O T Wiebenga, Menno Michiel Schoonheim, Hanneke Euphemia Hulst, G J A Nagtegaal, Eva M M Strijbis, Martijn D Steenwijk, C H Polman, Petra J W Pouwels, Frederik Barkhof, Jeroen J G Geurts
White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis. AJNR. American journal of neuroradiology 37 (6) (2016)